Japan Ministry Tables Proposal To Lower Second Visit Fees To Private Clinics
This article was originally published in PharmAsia News
The Central Insurance Medical Council of Japan's Ministry of Health, Labor and Welfare decided to table a proposal to lower patients' second visit fees to private clinics. The proposal was opposed by the Japan Medical Association, the trade association for private practices and clinic physicians. JMA waged a campaign that led to days worth of calls from local JMA branches and constituents to key Liberal Democratic Party members in Japan's Diet. (Click for more-Japanese language
You may also be interested in...
COVID-19 has pushed the entire health care system to adopt new technologies and new solutions for conducting clinical research and delivering care to patients. An expert panel hosted by the Galien Foundation provided a meditation on what the biopharma industry has learned so far, and how to use the urgency created by COVID-19 to lock-in technological acceleration while maintaining what FDA’s Amy Abernethy called “responsible progress.”
Zydus Cadila has clocked up two tentative and four final abbreviated new drug application approvals in a short amount of time, including for Boehringer Ingelheim’s Jentadueto and the discontinued verapamil hydrochloride for injection.
Pierre Bourdage, global head of biopharmaceuticals at Sandoz, has hit back at false statements and misleading claims around biosimilars that persist despite mounting evidence to the contrary.